Table 4.

Levels of the Main Lymphocyte Subgroups.

	Group 1	Group 2	Group 3	P
CD45+	Min-Max Mean ± SD
Before procedure	10.5–38.4	3–22.1	2.1–10.4	<.05*
	20.1 ± 10.6	8.3 ± 5.4	5.4 ± 2.6
Day 7	13.3–45.4	3.3–21.5	3.1–13	<.005*
	25.8 ± 10.1	8.7 ± 5.1	6.4 ± 4.3
HLADR+
Before procedure	0.1–0.8	0.4–3.1	0.5–4.1	NS
	0.5 ± 0.1	1.1 ± 0.5	0.7 ± 0.7
Day 7	0.9–2.3	0.3–2.1	0.6–4	<.05**
	1.7 ± 0.5	0.8 ± 0.6	1.8 ± 1.1
CD16+
Before procedure	41.2–75.3	50.4–61.8	50.3–62.5	NS
	58.1 ± 10.1	52.8 ± 3.9	52.2 ± 4.1
Day 7	43.9–77.2	57.2–82.5	38.8–83.3	<.05*
	59 ± 10.6	74 ± 7.9	63 ± 14.2
CD16+CD56+
Before procedure	0.4–6.3	0.2–1.3	0.1–1.5	<.05*
	2.4 ± 2.1	0.5 ± 0.2	0.2 ± 0.3
Day 7	0.4–6.2	0.5–2.4	0.1–1.4	<.05*
	2.5 ± 2	1.1 ± 0.6	0.6 ± 0.5
Granulocyte
Before procedure	28.6–76	50–74	33–81	<.05*
	52 ± 13.4	68 ± 8	60 ± 6.8
Day 7	28.9–77	52.3–81.2	41.9–82	<.05**
	52.2 ± 13.6	72.1 ± 10	64.5 ± 13.2
CD3+CD4+
Before procedure	28–52.4	15.7–65.2	15.7–65.1	NS
	41.3 ± 7.7	38.3 ± 8.9	42.1 ± 9.9
Day 7	30–54.4	17.7–67.2	29.7–66	NS
	42.3 ± 7.2	39.3 ± 14.2	44.6 ± 10.7
CD3+CD8+
Before procedure	11.7–42.6	7.8–43.4	15.7–43.8	NS
	26 ± 9.4	26.1 ± 8.6	24.6 ± 12.7
Day 7	16.4–42.6	17.5–43.4	14–75.8	NS
	26.4 ± 9.5	28.2 ± 8.6	28.4 ± 10.8

P-values following comparison between control groups (Group1 and Group-2) and the study group (Group-3) All values are given as minimum, maximum and mean, NS: not significant. * significant in favor of Group-1, ** significant in favor of Group-3 in comparison with Group-2 and Group-3.